Vaping cessation program for adolescent and young adult cancer survivors
Implementing an Adolescent and Young Adult (AYA) mHealth Vaping Cessation Program Into Oncology Clinics
NA · St. Jude Children's Research Hospital · NCT05967585
This study is testing a new vaping cessation program designed for young cancer survivors aged 13-24 to help them quit vaping and understand their vaping habits better.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 500 (estimated) |
| Ages | 13 Years to 24 Years |
| Sex | All |
| Sponsor | St. Jude Children's Research Hospital (other) |
| Locations | 1 site (Memphis, Tennessee) |
| Trial ID | NCT05967585 on ClinicalTrials.gov |
What this trial studies
This study aims to explore vaping behaviors among adolescent and young adult (AYA) cancer survivors aged 13-24 who are at least three months post-treatment. It will identify characteristics of their nicotine vaping behaviors and the factors influencing their interest in quitting. The study will utilize a mixed-methods approach, including qualitative interviews and questionnaires, to gather data from both survivors and healthcare providers. Based on the findings, the researchers will develop and implement a mobile health (mHealth) vaping cessation program tailored to this population.
Who should consider this trial
Good fit: Ideal candidates for this study are AYA cancer survivors aged 13-24 who are in remission and have completed cancer-directed therapy at least three months prior.
Not a fit: Patients with significant psychiatric or neurologic disorders that impair compliance with the study protocol may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly improve vaping cessation rates among young cancer survivors, enhancing their overall health and well-being.
How similar studies have performed: While there is limited research specifically targeting AYA cancer survivors, similar mHealth interventions for vaping cessation have shown promise in other populations.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Study Participants * Research participant is 13 to 24 years old at enrollment * Research participant is followed by St. Jude Children's Research Hospital (SJCRH) * Research participant has a diagnosis of malignancy or a CNS neoplasm * Research participant has been identified by the Transition Oncology Program (TOP) as a patient transitioning off active cancer therapy and/or followed by After Completion of Therapy (ACT) Clinic, and/or participating in the St. Jude Lifetime Cohort Study (SJLIFE) * Research participant is in remission and at least 3 months from having completed cancer-directed therapy * Participant can speak and read English Healthcare Providers * Engaged in the healthcare of survivors seen through TOP, ACT, or SJLIFE Exclusion Criteria: Study Participants * Significant psychiatric or neurologic disorders that would impair compliance with study protocol as indicated by the medical chart
Where this trial is running
Memphis, Tennessee
- St. Jude Children's Research Hospital — Memphis, Tennessee, United States (RECRUITING)
Study contacts
- Principal investigator: Rachel Webster, PhD — St. Jude Children's Research Hospital
- Study coordinator: Rachel Webster, PhD
- Email: referralinfo@stjude.org
- Phone: 8662785833
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Vaping, Vaping Cessation